This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, P. J.
Right arrow Articles by Babiuk, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, P. J.
Right arrow Articles by Babiuk, L. A.

 Previous Article  |  Next Article 

Journal of Virology, December 1999, p. 10214-10223, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Altering the Cellular Location of an Antigen Expressed by a DNA-Based Vaccine Modulates the Immune Response

P. J. Lewis,dagger S. van Drunen Littel-van den Hurk, and L. A. Babiuk*

Veterinary Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E3, Canada

Received 9 June 1999/Accepted 9 September 1999

The potential for DNA vaccines encoding mutated versions of the same antigen to modulate immune responses in C3H/HeN mice was investigated. We created expression plasmids that encoded several versions of glycoprotein D (gD) from bovine herpesvirus 1, including authentic membrane-anchored glycoprotein (pSLRSV.AgD), a secreted glycoprotein (pSLRSV.SgD), and an intracellular protein (pSLRSV.CgD). Immunization of an inbred strain of mice with these plasmids resulted in highly efficacious and long-lasting humoral and cell-mediated immunity. We also demonstrated that the cell compartment in which plasmid-encoded gD was expressed caused a deviation in the serum immunoglobulin (Ig) isotype profile as well as the predominant cytokines secreted from the draining lymph node. Immunization of C3H/HeN mice with DNA vaccines encoding cell-associated forms of gD resulted in a predominance of serum IgG2a and gamma interferon-secreting cells within the spleens and draining lymph nodes. In contrast, mice immunized with a secreted form of this same antigen displayed immune responses characterized by greater levels of interleukin 4 in the draining lymph node and IgG1 as the predominant serum isotype. We also showed evidence of compartmentalization of distinct immune responses within different lymphoid organs.


* Corresponding author. Mailing address: Veterinary Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Rd., Saskatoon, Saskatchewan S7N 5E3, Canada. Phone: (306) 966-7465. Fax: (306) 966-7478. E-mail: babiuk{at}sask.usask.ca.

dagger Present address: Department of Pathology and Microbiology, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Prince Edward Island C1A 4P3, Canada.


Journal of Virology, December 1999, p. 10214-10223, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Arruda, L. B., Sim, D., Chikhlikar, P. R., Maciel, M. Jr, Akasaki, K., August, J. T., Marques, E. T. A. (2006). Dendritic Cell-Lysosomal-Associated Membrane Protein (LAMP) and LAMP-1-HIV-1 Gag Chimeras Have Distinct Cellular Trafficking Pathways and Prime T and B Cell Responses to a Diverse Repertoire of Epitopes. J. Immunol. 177: 2265-2275 [Abstract] [Full Text]  
  • Lauterbach, H., Gruber, A., Ried, C., Cheminay, C., Brocker, T. (2006). Insufficient APC Capacities of Dendritic Cells in Gene Gun-Mediated DNA Vaccination.. J. Immunol. 176: 4600-4607 [Abstract] [Full Text]  
  • Yu, H., Huang, H., Xiang, J., Babiuk, L. A., van Drunen Littel-van den Hurk, S. (2006). Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. J. Gen. Virol. 87: 1-10 [Abstract] [Full Text]  
  • Ko, H.-J., Ko, S.-Y., Kim, Y.-J., Lee, E.-G., Cho, S.-N., Kang, C.-Y. (2005). Optimization of Codon Usage Enhances the Immunogenicity of a DNA Vaccine Encoding Mycobacterial Antigen Ag85B. Infect. Immun. 73: 5666-5674 [Abstract] [Full Text]  
  • Huang, Y., Babiuk, L. A., van Drunen Littel-van den Hurk, S. (2005). Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J. Gen. Virol. 86: 887-898 [Abstract] [Full Text]  
  • Yu, H., Babiuk, L. A., van Drunen Littel-van den Hurk, S. (2004). Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3. J. Gen. Virol. 85: 1533-1543 [Abstract] [Full Text]  
  • Youn, J.-W., Park, S.-H., Cho, J. H., Sung, Y. C. (2003). Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization. J. Virol. 77: 11596-11602 [Abstract] [Full Text]  
  • Rush, C., Mitchell, T., Garside, P. (2002). Efficient Priming of CD4+ and CD8+ T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways. J. Immunol. 169: 4951-4960 [Abstract] [Full Text]  
  • Marsac, D., Loirat, D., Petit, C., Schwartz, O., Michel, M.-L. (2002). Enhanced Presentation of Major Histocompatibility Complex Class I-Restricted Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Specific Epitopes after DNA Immunization with Vectors Coding for Vesicular Stomatitis Virus Glycoprotein- Pseudotyped HIV-1 Gag Particles. J. Virol. 76: 7544-7553 [Abstract] [Full Text]  
  • Qiu, J.-T., Liu, B., Tian, C., Pavlakis, G. N., Yu, X.-F. (2000). Enhancement of Primary and Secondary Cellular Immune Responses against Human Immunodeficiency Virus Type 1 Gag by Using DNA Expression Vectors That Target Gag Antigen to the Secretory Pathway. J. Virol. 74: 5997-6005 [Abstract] [Full Text]